Companies /Basic Materials
Chemours Company
NYSE: CC Specialty Chemicals
$12.09
▼ $0.09 (−0.74%) today
Markets open · 2:33pm ET

Chemours Company (CC) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
CC vs Market · 30-day return after each reportCCS&P 500
0%+20%+35.4%+2.5%Q2 25+4.4%+2.5%Q3 25+19.5%−5.3%Q4 25−11.9%+0.7%Q1 26+4.9%+0.1%Q2 26
0%+20%Q2 25Q3 25Q4 25Q1 26Q2 26
CC EPS Trend · estimate vs actualEstimateActual
$0.00$0.20$0.40$0.60$0.46$0.58Q2 25$0.24$0.20Q3 25$0.02$0.05Q4 25$-0.04$0.05Q1 26$0.42$0.42Q2 26$0.26$0.21Q3 26
$0.00$0.20$0.40$0.60Q2 25Q4 25Q2 26
CC Revenue Trend · estimate vs actualEstimateActual
$0$500.0M$1.0B$1.5B$1.6B$1.6BQ2 25$1.5B$1.5BQ3 25$1.3B$1.3BQ4 25$1.4B$1.4BQ1 26$1.7B$1.6BQ2 26$1.5B$1.5BQ3 26
$0$500.0M$1.0B$1.5BQ2 25Q4 25Q2 26

How Often Does Chemours Company Beat Earnings Estimates?

Chemours Company beat EPS estimates in 4 of its last 6 reported quarters.

CC quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 Adjusted EPS excludes items included in GAAP diluted EPS of $1.29. These include $150 million received under the PFAS insurance proceeds MOU (recorded as a reduction to SG&A), net litigation-related income of $138 million, a $50 million gain on sales of assets (Kuan Yin land) and $18 million of environmental charges. $0.21 est. $0.26 −18.51% $1.5B est. $1.5B +0.50%
Q2 2026 $0.42 est. $0.42 +0.07% $1.6B est. $1.7B −3.95%
Q1 2026 $0.05 est. $-0.04 +223.76% $1.4B est. $1.4B −1.28%
Q4 2025 $0.05 est. $0.02 +192.40% $1.3B est. $1.3B +0.05%
Q3 2025 $0.20 est. $0.24 −17.22% $1.5B est. $1.5B −0.20%
Q2 2025 $0.58 est. $0.46 +26.94% $1.6B est. $1.6B +3.08%

Figures from SEC filings and company reports. Not investment advice.